Due to the profound roles of EZH2 and p53 in determining the aggressivity and prognosis of HNSCC, we aimed to compare their expression in young patients and the general HNSCC patient population to further characterize the nature of this greater risk that might result in early disease onset. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.